Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1997-11-19
2000-02-15
Krass, Frederick
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514341, 514365, 514372, 514374, 514378, 514399, 514400, 514403, 514406, 514407, A61K 4356
Patent
active
060253533
ABSTRACT:
This invention relates to the use of cyclooxygenase-2 inhibitors or derivatives thereof in preventing and treating angiogenic disorders.
REFERENCES:
patent: 5344991 (1994-09-01), Reitz et al.
patent: 5380738 (1995-01-01), Norman et al.
patent: 5393790 (1995-02-01), Reitz et al.
patent: 5434178 (1995-07-01), Talley et al.
patent: 5466823 (1995-11-01), Talley et al.
patent: 5474995 (1995-12-01), Ducharme et al.
patent: 5475018 (1995-12-01), Lee et al.
patent: 5510368 (1996-04-01), Lau et al.
patent: 5521207 (1996-05-01), Graneto
patent: 5646136 (1997-07-01), Petrow et al.
patent: 5760068 (1998-06-01), Talley et al.
Bouck, N. et al., "How Tumors Become Angiogenic", Advances in Cancer Research, vol. 69, pp. 136-173, 1996.
Ferrera, N. et al., "The Biology of Vascular Endothelial Growth Factor", Endocrine Reviews, vol. 18, No. 1, pp. 4-25, 1997.
Folkman, J., "Angiogenesis in Cancer, Vascular, Rheumatoid and Other Disease", Nature Medicine, vol. 1, No. 1, pp. 27-31, 1995.
Form, D.M. et al., "PGE.sub.2 and Angiogenesis", Proceedings of the Society for Experimental Biology and Medicine, vol. 172, pp. 214-218, 1983.
Fujii, E. et al., "Role of Nitric Oxide, Prostaglandins and Tyrosine Kinase in Vascular Endothelial Growth Factor-Induced Increase in Vascular Permeability in Mouse Skin", Naunyn-Schmiedeberg's Arch. Pharmacol., vol. 356, pp. 475-480, 1997.
Hamilton, J.A., "Hypothesis: In Vitro Evidence for the Invasive and Tumor-Like Properties of the Rheumatoid Pannus", The Journal of Rheumatology, vol. 10:6, pp. 845-851, 1983.
Heldin, C., "Structural and Functional Studies on Platelet-Derived Growth Factor", The EMBO Journal, vol. 11, No. 12, pp. 4251-4259, 1992.
Hla, T. et al., "Role of the Early Response Gene Cyclooxygenase (Cox)-2 in Angiogenesis", Molecular, Cellular, and Clinical Aspects of Angiogenesis, pp. 191-198, 1996.
Huang et al., "Cyclooxygenase and 5-Lipoxygenase Inhibitors for the Prevention and Treatment of Cancer", Expert Opinion on Investigational Drugs, vol. 4(3), pp. 243-249, 1995.
Lala, P.K. et al., "Effects of Chronic Indomethacin Therapy on the Development and Progression of Spontaneous Mamary Tumors in C3H/HEJ Mice", Int. J. Cancer, vol. 73, pp. 371-380, 1997.
McGough, K.A. et al., "Inflammatory PGE.sub.2 Production is Maintained During Hypoxia in Rheumatoid Synovial Fibroblasts", Inflammation Research, vol. 46, Supplement 2, pp. S147-S148, 1997.
Murohara, T. et al., "Vascular Endothelial Growth Factor/Vascular Permeability Factor Enhances Vascular Permeability Via Nitric Oxide and Prostacyclin", Circulation, vol. 97, pp. 99-107, 1998.
Nagashima, M. et al., "Role of Vascular Endothelial Growth Factor in Angiogenesis of Rheumatoid Arthritis", The Journal of Rheumatology, vol. 22, pp. 1624-1630, 1995.
Peterson, H., "Tumor Angiogenesis Inhibition by Prostaglandin Synthetase Inhibitors", Anticancer Research, vol. 6, pp. 251-254, 1986.
Ristimaki, A. et al., "Effect of Growth Factors on Human Vascular Endothelial Cell Prostacyclin Production", Arteriosclerosis, vol. 10, No. 4, pp. 653-657, 1990.
Sano, H. et al., "Expression of Cyclooxygenase-1 and -2 in Human Colorectal Cancer", Cancer Research, vol. 55, pp. 3785-3789, 1995.
Sano, H. et al., "In Vivo Cyclooxygenase Expression in Synovial Tissues of Patients With Rheumatoid Arthritis and Osteoarthritis and Rats With Adjuvant and Streptococcal Cell Wall Arthritis", The Journal of Clinical Investigation, Inc., vol. 89, pp. 97-108, 1992.
Seed, M.P. et al., "The Inhibition of Colon-26 Adenocarcinoma Development and Angiogenesis by Topical Diclofenac in 2.5% Hyaluronan", Cancer Research, vol. 57, pp. 1625-1629, 1997.
Ziche, M. et al., "Nitric Oxide Mediates Angiogenesis In Vivo and Endothelial Cell Growth and Migration In Vitro Promoted by Substance P", J. Clin. Invest., vol. 94, pp. 2036-2044, 1994.
"Role of the Early Response Gene Cyclooxygenase (Cox-2) in Angiogenesis", Chemical Abstracts 125:297565.
Abstract XP002061819 (Doc. Opthalmol., 57/3, pp. 215-262, 1984).
Abstract XP002061818 (Expert Opin. Invest. Drugs, 5/12, pp. 1617-1637, 1996).
Chemical Abstracts 125:297,565, "Role of the Early Response Gene Cyclooxygenase (Cox-2) in Angiogenesis", Feb. 1996.
Huang et al, "Expert Opinion on Investigational Drugs", pp. 243-249, Mar. 1995.
Masferrer Jaime
Raz Amiram
Bulock Joseph W.
G.D. Searle & Co.
Krass Frederick
LandOfFree
Method of using cyclooxygenase-2 inhibitors as anti-angiogenic a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of using cyclooxygenase-2 inhibitors as anti-angiogenic a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of using cyclooxygenase-2 inhibitors as anti-angiogenic a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1906088